March 20th 2025
A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Satellite Symposia at the 2025 Oncology Nursing Society Congress
April 11-12, 2025
Register Now!
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
An Overlooked Connection: Serotonergic Mediation of Estrogen-related Physiology and Pathology
July 28th 2011In humans, serotonin has typically been investigated as a neurotransmitter. However, serotonin also functions as a hormone across animal phyla, including those lacking an organized central nervous system.
Read More
Breast Cancer in Younger Women Assessment and Risk Management
July 28th 2011Breast cancer is a growing concern among premenopausal women. With an emphasis on this patient population, this article discusses the known risk factors for breast cancer; models for quantitative risk assessment; and strategies for modifying breast cancer risk, including screening mammography, prophylactic mastectomy, and primary pharmacologic prevention.
Read More
Hormone Replacement Therapy and Mammogram Accuracy
July 28th 2011A report just published in the Journal of the American Medical Association confirmed previous studies which found that women who take hormone replacement therapy (HRT) may develop denser breast tissue, which in turn may make it more difficult to detect breast cancer through mammography.
Read More
OCs for Perimenopausal Women: Who Might Benefit from the Pill?
July 28th 2011Healthy, nonsmoking perimenopausal women can derive a host of benefits from using oral contraceptives (OCs). Along with providing effective contraception, OCs can regulate their menstrual cycles, reduce hot flashes, and protect against two gynecologic cancers.
Read More
Don't Wait for a Fracture Identifying Osteoporosis
July 28th 2011Like the proverbial elephant, osteoporosis has been described in ways that vary according to the scientific orientation of the describer. It has been defined clinically as the presence of fracture; biomechanically as decreased bone strength; radiographically as osteopenia; histomorphometrically as reduced bone matrix per unit of bone volume; and epidemiologically as increased fracture risk.
Read More
Update on Retropubic Incontinence Surgery
July 28th 2011A 27-year study of 1300 women undergoing retropubic cystourethropexy using either the modified Marshall-Marchetti-Krantz procedure or the modified Pereyra procedure compares long-term results when the type of surgery is selected on the basis of patient criteria.
Read More
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain.
Read More
European Active Surveillance Study of Women Taking HRT (EURAS-HRT): Study Protocol [NCT00214903]
July 27th 2011The post marketing safety surveillance program for a drug containing a new chemical entity should assess both, the safety outcomes that relate specifically to the targeted population, as well as those that could potentially be related to special pharmacological characteristics of the drug.
Read More
Discordance in Diagnosis of Osteoporosis using Spine and Hip Bone Densitometry
July 27th 2011Diagnostic discordance for osteoporosis is the observation that the T-score of an individual patient varies from one key measurement site to another, falling into two different diagnostic categories identified by the World Health Organization (WHO) classification system.
Read More
A Discussion of Natural Hormones
July 26th 2011The request for "natural hormones" is nearly universal. But there is a lot of misunderstanding regarding this idea. What is natural? Compounds derived from nature? Or compounds from pharmaceutical companies that are structurally similar to hormones produced by the ovaries?
Read More
Podcast: What Should You Tell Your Patients About Bioidentical Hormones?
July 18th 2011Menopausal women often present with a list of complaints, questions and worries. While they seek effective treatment to alleviate their symptoms, they express their concerns regarding the potential adverse effects associated with conventional hormone treatment-namely, coronary heart disease, stroke and breast cancer. As a result, many women ask their clinicians about alternative options. They come armed with anecdotal stories, advice from friends, and information from television and internet sources.
Read More
Walk Time Provides Useful Health Indicator Information for Postmenopausal Women
July 18th 2011The 400-meter timed walk can provide insights into an older person’s cardiorespiratory fitness; the resulting data from these walks are useful in predicting total mortality, cardiovascular disease, mobility limitation, and disability. But do leisure time activities and weight/body composition changes affect walk time? Dr Kelley K. Pettee Gabriel from the division of epidemiology, human genetics, and environmental sciences at the University of Texas Health Science Center, Austin, and colleagues believe a better understanding of this relationship will help clarify the best use of the 400-meter walk in middle-aged women.
Read More